Common Ozempic side effects include: Weight loss Gastrointestinal symptoms, such as nausea, constipation, diarrhea, and abdominal pain Eye symptoms, such as diabetic retinopathy Low blood sugar, characterized by lightheadedness Injection site reactions, such as pain or redness Serious side effects include: Thyroid tumors Angioedema (swelling of tissues in the face, eyes, and lips) Acute kidney injury Worsening of kidney disease Pancreatitis (inflammation of the pancreas) Gallbladder inflammation (cholecystitis) Cholelithiasis (gallstones) Gastroparesis (stomach paralysis) Syncope (fainting and loss of consciousness) Serious side effects should be reported to a healthcare provider immediately
Gastrointestinal adverse events, including diarrhoea, nausea, and vomiting, were consistently the most common side effects reported across all dose groups in the phase 2 trial
Real-world analysis of glucagon-like peptide-1 agonist (GLP-1a) obesity treatment one year cost-effectiveness and therapy adherence
Massive and rapid infusion through an intravenous line might be hard on the kidneys, or it could even trigger an unusual skin reaction
With TRIUMPH-2 and TRIUMPH-3 now added to the data package, Lilly has confirmed it is preparing a submission covering obesity, knee osteoarthritis pain, and obstructive sleep apnea indications a broader filing than originally anticipated, which accounts for the shift in timing
Regular blood pressure monitoring is an important component of comprehensive care for patients taking tirzepatide, particularly given the medication's effects on weight and metabolic parameters